Legler, Franziska, Meyer-Arndt, Lil, Mödl, Lukas et al. · EClinicalMedicine · 2023 · DOI
This study followed 106 people with long-term fatigue after COVID-19 for up to 20 months to see how they recovered over time. Researchers found that some patients met the diagnostic criteria for ME/CFS and had persistent, severe symptoms including fatigue and post-exertional malaise (worsening after activity), while others improved more substantially. Lower muscle strength at the start of illness was linked to ongoing symptoms, especially in those with ME/CFS.
This study provides evidence that ME/CFS is a distinct subgroup within post-COVID illness with a different disease trajectory and persistent severity, supporting the use of diagnostic criteria to identify patients who need specialized monitoring and management. The findings validate ME/CFS diagnostic criteria in a post-COVID context and highlight that some post-COVID patients develop genuine ME/CFS rather than simply experiencing prolonged recovery.
This study does not establish that reduced grip strength or any biomarker *causes* symptom persistence—only that they are correlated. The study also does not explain the biological mechanisms underlying ME/CFS or why some post-COVID patients develop ME/CFS while others recover. Additionally, findings in this German cohort may not generalize to other populations or disease variants.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.